CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 36.54
+5.44 (17.49%)
Sep 30, 2026, 4:08 PM HKT
CanSino Biologics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,337 | 1,329 | 2,023 | 2,822 | 3,465 | 5,645 |
Short-Term Investments | - | 326.32 | - | - | - | 275.2 |
Trading Asset Securities | 506.38 | 987.97 | 1,182 | 1,308 | 2,482 | 1,862 |
Cash & Short-Term Investments | 1,844 | 2,644 | 3,204 | 4,130 | 5,947 | 7,783 |
Cash Growth | -43.67% | -17.50% | -22.41% | -30.55% | -23.59% | 52.19% |
Accounts Receivable | 959.99 | 782.88 | 737.62 | 636.88 | 855.49 | 157.93 |
Other Receivables | 45.65 | 4.9 | 10 | 3.98 | 0.54 | 19.15 |
Receivables | 1,042 | 787.79 | 747.62 | 640.87 | 856.03 | 177.08 |
Inventory | 387.74 | 347.85 | 283.41 | 352.85 | 677.78 | 875.62 |
Prepaid Expenses | - | - | - | 0.25 | - | - |
Other Current Assets | -43.5 | 59.45 | 47.08 | 57 | 249.59 | 454.49 |
Total Current Assets | 3,230 | 3,839 | 4,282 | 5,181 | 7,730 | 9,290 |
Property, Plant & Equipment | 2,563 | 2,611 | 2,641 | 3,013 | 3,069 | 2,218 |
Long-Term Investments | 475.59 | 162.09 | 483.71 | 446.56 | 50.12 | 45.31 |
Other Intangible Assets | 244.32 | 188.75 | 115.49 | 144.15 | 220.92 | 172.12 |
Long-Term Deferred Tax Assets | 204.79 | 211.55 | 205.39 | 207.86 | 196.41 | - |
Long-Term Deferred Charges | 79.77 | 137.93 | 172.21 | 88.4 | 51.95 | 26.19 |
Other Long-Term Assets | 27.38 | 27.34 | 57.99 | 237.53 | 150.37 | 122.42 |
Total Assets | 6,825 | 7,178 | 7,958 | 9,319 | 11,469 | 11,874 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 43.77 | 50.44 | 62.47 | 103.97 | 253.12 | 842.57 |
Accrued Expenses | 408.04 | 456.29 | 400.08 | 453.14 | 407.25 | 362.44 |
Short-Term Debt | 20 | 73.22 | 377.35 | 883.97 | 1,530 | 990.68 |
Current Portion of Long-Term Debt | 46.28 | 245.31 | 514.82 | 510.59 | 45.77 | 90.11 |
Current Portion of Leases | 4.85 | 5.43 | 9.99 | 64.63 | 48.76 | 31.18 |
Current Income Taxes Payable | 4.45 | 5.12 | 4.66 | 0.54 | 3 | 29.14 |
Current Unearned Revenue | 20.96 | 18.23 | 14.69 | 3.57 | 1.48 | 193.22 |
Other Current Liabilities | 187.19 | 190.98 | 302.68 | 544.9 | 635.52 | 322.08 |
Total Current Liabilities | 735.55 | 1,045 | 1,687 | 2,565 | 2,925 | 2,861 |
Long-Term Debt | 900.21 | 956.95 | 1,099 | 1,066 | 878.01 | 40 |
Long-Term Leases | 9.29 | 7.62 | 12.68 | 175.18 | 198.29 | 222.85 |
Long-Term Unearned Revenue | 202.19 | 214.38 | 250.3 | 216.72 | 222.35 | 201.48 |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.56 |
Other Long-Term Liabilities | - | - | - | 8.49 | - | - |
Total Liabilities | 1,847 | 2,224 | 3,048 | 4,031 | 4,223 | 3,326 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 247.04 | 247.04 | 247.45 | 247.45 | 247.45 | 247.45 |
Additional Paid-In Capital | 5,190 | 5,165 | 6,577 | 6,574 | 6,608 | 6,598 |
Retained Earnings | -459.8 | -459.08 | -1,819 | -1,440 | 42.71 | 1,150 |
Treasury Stock | - | - | -95.62 | -106.17 | -150.17 | - |
Comprehensive Income & Other | 0.19 | 0.19 | 0.22 | -0.18 | 0.12 | - |
Total Common Equity | 4,978 | 4,954 | 4,910 | 5,275 | 6,748 | 7,995 |
Minority Interest | - | - | - | 12.81 | 497.51 | 552.84 |
Shareholders' Equity | 4,978 | 4,954 | 4,910 | 5,287 | 7,246 | 8,548 |
Total Liabilities & Equity | 6,825 | 7,178 | 7,958 | 9,319 | 11,469 | 11,874 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 980.64 | 1,289 | 2,013 | 2,700 | 2,701 | 1,375 |
Net Cash (Debt) | 863.11 | 1,355 | 1,191 | 1,430 | 3,246 | 6,408 |
Net Cash Growth | -37.65% | 13.79% | -16.70% | -55.95% | -49.34% | 28.90% |
Net Cash Per Share | 3.49 | 5.35 | 4.81 | 5.80 | 13.14 | 25.91 |
Filing Date Shares Outstanding | 247.04 | 247.04 | 249.18 | 247.04 | 246.77 | 247.45 |
Total Common Shares Outstanding | 247.04 | 247.04 | 249.18 | 247.04 | 246.77 | 247.45 |
Working Capital | 2,494 | 2,794 | 2,596 | 2,616 | 4,805 | 6,428 |
Book Value Per Share | 20.15 | 20.05 | 19.70 | 21.35 | 27.35 | 32.31 |
Tangible Book Value | 4,734 | 4,765 | 4,794 | 5,130 | 6,527 | 7,823 |
Tangible Book Value Per Share | 19.16 | 19.29 | 19.24 | 20.77 | 26.45 | 31.61 |
Buildings | 1,353 | 1,294 | 1,025 | 978.89 | 729.03 | 724.68 |
Machinery | 943.31 | 878.09 | 773.61 | 1,189 | 1,050 | 537.75 |
Construction In Progress | 925.57 | 1,021 | 1,268 | 1,114 | 1,342 | 820.8 |